Tabomedex Biosciences, Inc.
About:
Tabomedex focuses on the R&D of new drugs related to type 2 diabetes.
Website: http://tabomedex.com/
Top Investors: Viva BioInnovator, JMCR Partners, Viva Ventures Biotech Fund
Description:
Tabomedex focuses on the R&D of new drugs related to type 2 diabetes. They mainly study the mechanism of action of MK2 and achieve the effect of controlling blood glucose level by inhibiting MK2, namely inhibiting the effect of downstream avtivating enzymes.
Total Funding Amount:
$5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2013-01-01
Contact Email:
alice(AT)tabomedex.com
Founders:
Ira Tabas, Lale Ozcan
Number of Employees:
1-10
Last Funding Date:
2020-08-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai